✦ LIBER ✦

Cancer Stem Cell Marker Bmi-1 Expression is Associated with Basal-like Phenotype and Poor Survival in Breast Cancer

✍ Scribed by Yanyang Wang; Hong Zhe; Zhe Ding; Ping Gao; Ningmei Zhang; Guofu Li

Book ID: 113027456
Publisher: Springer
Year: 2012
Tongue: English
Weight: 376 KB
Volume: 36
Category: Article
ISSN: 0364-2313
DOI: 10.1007/s00268-012-1514-3

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

B5. iNOS expression is associated with b

B5. iNOS expression is associated with basal-like breast cancer phenotype and predicts poor survival in ERneg breast cancer

✍ S. Glynn; B. Boersma; D. Martin; T. Howe; L. Ridnour; D. Wink; M. Yi; R. Stephen 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 48 KB

Numb protein expression correlates with

Numb protein expression correlates with a basal-like phenotype and cancer stem cell markers in primary breast cancer

✍ Karin Rennstam; Nicole McMichael; Pontus Berglund; Gabriella Honeth; Cecilia Heg 📂 Article 📅 2009 🏛 Springer US 🌐 English ⚖ 510 KB

Independent prognostic value of the basa

Independent prognostic value of the basal-like phenotype of breast cancer and associations with EGFR and candidate stem cell marker BMI-1

✍ J B Arnes; K Collett; L A Akslen 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 181 KB

Caveolin-1 expression is associated with

Caveolin-1 expression is associated with a basal-like phenotype in sporadic and hereditary breast cancer

✍ Socorro María Rodríguez Pinilla; Emiliano Honrado; David Hardisson; Javier Benít 📂 Article 📅 2006 🏛 Springer US 🌐 English ⚖ 365 KB

High cyclin B1 expression is associated

High cyclin B1 expression is associated with poor survival in breast cancer

✍ Aaltonen, K; Amini, R-M; Heikkilä, P; Aittomäki, K; Tamminen, A; Nevanlinna, H; 📂 Article 📅 2009 🏛 Nature Publishing Group 🌐 English ⚖ 149 KB

PI3K pathway activation in breast cancer

PI3K pathway activation in breast cancer is associated with the basal-like phenotype and cancer-specific mortality

✍ Elena López-Knowles; Sandra A. O'Toole; Catriona M. McNeil; Ewan K.A. Millar; Mi 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 French ⚖ 552 KB

## Abstract Breast cancer is a common malignancy with current biological therapies tailored to steroid hormone (ER, PR) and HER2 receptor status. Understanding the biological basis of resistance to current targeted therapies and the identification of new potential therapeutic targets is an ongoing